Interferon enhances immune-checkpoint inhibition

被引：3
作者：
Romero D.
机构：
[1] Nature Reviews Clinical Oncology,
来源：
Nature Reviews Clinical Oncology | 2019年 / 16卷 / 1期
关键词：
D O I：
10.1038/s41571-018-0128-6
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [41] Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade
    Chon, Hong Jae
    Lee, Won Suk
    Yang, Hannah
    Kong, So Jung
    Lee, Na Keum
    Moon, Eun Sang
    Choi, Jiwon
    Han, Eun Chun
    Kim, Joo Hoon
    Ahn, Joong Bae
    Kim, Joo Hang
    Kim, Chan
    CLINICAL CANCER RESEARCH, 2019, 25 (05) : 1612 - 1623
  • [42] Targeting β-Catenin Enhances Immune Checkpoint Inhibition Efficacy in Osteosarcoma
    Nakahata, K.
    Nirala, B.
    Kurenbekova, L.
    Shuck, R.
    Yustein, J.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S250 - S250
  • [43] Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition
    Junk, David
    Kraemer, Sebastian
    Broschewitz, Johannes
    Laura, Hennig
    Massa, Chiara
    Moulla, Yousef
    Hoang, Ngoc Anh
    Monecke, Astrid
    Eichfeld, Uwe
    Bechmann, Ingo
    Lordick, Florian
    Seliger, Barbara
    Kallendrusch, Sonja
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [44] Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
    D'Abreo, Nina
    Adams, Sylvia
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (07) : 399 - 400
  • [45] Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
    Zhou, Jingying
    Liu, Man
    Sun, Hanyong
    Feng, Yu
    Xu, Liangliang
    Chan, Anthony W. H.
    Tong, Joanna H.
    Wong, John
    Chong, Charing Ching Ning
    Lai, Paul B. S.
    Wang, Hector Kwong-Sang
    Tsang, Shun-Wa
    Goodwin, Tyler
    Liu, Rihe
    Huang, Leaf
    Chen, Zhiwei
    Sung, Joseph J. Y.
    Chow, King Lau
    To, Ka Fai
    Cheng, Alfred Sze-Lok
    GUT, 2018, 67 (05) : 931 - 944
  • [46] Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition
    Vylyny Chat
    Robert Ferguson
    Danny Simpson
    Esther Kazlow
    Rebecca Lax
    Una Moran
    Anna Pavlick
    Dennie Frederick
    Genevieve Boland
    Ryan Sullivan
    Antoni Ribas
    Keith Flaherty
    Iman Osman
    Jeffrey Weber
    Tomas Kirchhoff
    Cancer Immunology, Immunotherapy, 2019, 68 : 897 - 905
  • [47] Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition
    Chat, Vylyny
    Ferguson, Robert
    Simpson, Danny
    Kazlow, Esther
    Lax, Rebecca
    Moran, Una
    Pavlick, Anna
    Frederick, Dennie
    Boland, Genevieve
    Sullivan, Ryan
    Ribas, Antoni
    Flaherty, Keith
    Osman, Iman
    Weber, Jeffrey
    Kirchhoff, Tomas
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (06) : 897 - 905
  • [48] Future directions in immune-checkpoint inhibitors in NSCLC
    Hayashi, Hidetoshi
    CANCER SCIENCE, 2018, 109 : 1225 - 1225
  • [49] Role of immune-checkpoint inhibitors in lung cancer
    Jain, Prantesh
    Jain, Chhavi
    Velcheti, Vamsidhar
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [50] Immune-checkpoint blockade — durable cancer control
    Elizabeth I. Buchbinder
    F. Stephen Hodi
    Nature Reviews Clinical Oncology, 2016, 13 : 77 - 78
12345